中医领域2型糖尿病Metellius临床试验中的依从性报告。
Adherence reporting in clinical trials of type 2 Diabetes Metellius in the field of Traditional Chinese Medicine.
作者信息
Xing Dongmei, Zhang Junhua, Zhu Mingjun, Zhao Yu, Shang Hongcai
出版信息
J Tradit Chin Med. 2017 Feb;37(1):140-2. doi: 10.1016/s0254-6272(17)30037-7.
OBJECTIVE
To assess the medication adherence reporting in clinical trials the field of Traditional Chinese Medicine (TCM) and the impact factors of medication adherence.
METHODS
Reviewed and evaluated were all randomized clinical trials in the field of TCM in treatment of type 2 diabetes mellitus published in Chinese journals in 2012, in terms of their medication adherence, adherence measurement, and impacted factors of adherence.
RESULTS
Finally 124 studies were included. None studies reported the medication adherence. The factors impacting medication adherence couldn'tbe analyzed due to none reporting adherence.
CONCLUSION
Medication adherence reporting was poor in clinical trials in TCM research. Establishing standards for adherence assessment and reporting may be one of the important steps to improve the quality of clinical studies.
目的
评估中医药领域临床试验中的用药依从性报告情况以及用药依从性的影响因素。
方法
对2012年发表于中文期刊的中医药领域治疗2型糖尿病的所有随机临床试验，就其用药依从性、依从性测量方法以及依从性的影响因素进行回顾和评价。
结果
最终纳入124项研究。无一研究报告用药依从性。由于无一研究报告依从性，因此无法分析影响用药依从性的因素。
结论
中医药研究的临床试验中用药依从性报告情况较差。建立依从性评估和报告标准可能是提高临床研究质量的重要步骤之一。
Zotero 插件